Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate

被引:16
作者
Boffito, M
Pozniak, A
Kearney, BP
Higgs, C
Mathias, A
Zhong, LJ
Shah, J
机构
[1] Chelsea & Westminster Hosp, PK Res, St Stephens Ctr, London SW10 9NH, England
[2] Gilead Sci Inc, Foster City, CA USA
关键词
D O I
10.1128/AAC.49.10.4386-4389.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A study explored the pharmacokinetics of tenofovir (300 mg administered once daily) and nelfinavir (1,250 mg twice daily) when coadministered in 29 healthy volunteers. Tenofovir, nelfinavir, and M8 pharmacolkinetics was unaltered when tenofovir and neltinavir were coadministered, and tenofovir administration did not affect the M8/nelfinavir area under the concentration-versus-time curve over the dosing interval (AUC(tau)) ratio. No interaction between tenofovir and nelfinavir was observed.
引用
收藏
页码:4386 / 4389
页数:4
相关论文
共 14 条
[11]  
POIRIER J, 2002, 42 INT C ANT AG CHEM
[12]  
*ROCH, 2004, VIR NELF SUMM PROD C
[13]   Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection a randomized trial [J].
Squires, K ;
Pozniak, AL ;
Pierone, G ;
Steinhart, CR ;
Berger, D ;
Bellos, NC ;
Becker, SL ;
Wulfsohn, M ;
Miller, MD ;
Toole, JJ ;
Coakley, DF ;
Cheng, A .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) :313-320
[14]  
ZONG J, 2004, 44 INT C ANT AG CHEM